These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8999152)

  • 1. [New aspects of anti-inflammatory therapy of rheumatic diseases: preclinical validation and clinical trial of meloxicam].
    Nasonov EL; Tsvetkova ES; Balabanova RM; Denisov LN; Alekseeva LI; Nasonova VA
    Klin Med (Mosk); 1996; 74(4):4-8. PubMed ID: 8999152
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety of meloxicam: a global analysis of clinical trials [British Journal of Rheumatology, 1996;35(suppl. 1):68-77].
    Fenn GC; Morant SV
    Br J Rheumatol; 1997 Jul; 36(7):817-9. PubMed ID: 9255122
    [No Abstract]   [Full Text] [Related]  

  • 3. [Meloxicam (Movalis)].
    Kaliterna DM
    Reumatizam; 2007; 54(2):81-2. PubMed ID: 18351150
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharma-Clinics. The drug of the month. Meloxicam (Mobic)].
    Scheen AJ
    Rev Med Liege; 1997 Apr; 52(4):309-11. PubMed ID: 9273628
    [No Abstract]   [Full Text] [Related]  

  • 5. [Efficacy and intolerance of meloxicam in injection and tablet form].
    Tiurin VP; Rakov AL
    Voen Med Zh; 2003 Nov; 324(11):54-8. PubMed ID: 14725079
    [No Abstract]   [Full Text] [Related]  

  • 6. [Meloxicam: intramuscular administration in rheumatology].
    Tsvetkova ES
    Ter Arkh; 2003; 75(8):96-7. PubMed ID: 14520864
    [No Abstract]   [Full Text] [Related]  

  • 7. [Meloxicam--the balance of efficacy and safety].
    Morović-Vergles J
    Reumatizam; 2008; 55(2):85-6. PubMed ID: 19024285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy and tolerance of stepwise therapy with movalis in rheumatic diseases].
    Tsetkova ES
    Ter Arkh; 2004; 76(12):78-80. PubMed ID: 15724934
    [No Abstract]   [Full Text] [Related]  

  • 9. [The new nonsteroidal anti-inflammatory preparation meloxicam in the treatment of rheumatoid arthritis].
    Grishina EI
    Lik Sprava; 1997; (2):19-25. PubMed ID: 9333474
    [No Abstract]   [Full Text] [Related]  

  • 10. Meloxicam (Mobic) for osteoarthritis.
    Med Lett Drugs Ther; 2000 May; 42(1079):47-8. PubMed ID: 10859731
    [No Abstract]   [Full Text] [Related]  

  • 11. [From the COX-concept (Cyclooxygenase-2) to clinical gain. Meloxicam sets the standard. World-wide interactive video conference, London, 26 September 1997].
    Z Orthop Ihre Grenzgeb; 1997; 135(6 Suppl):1-4. PubMed ID: 9474258
    [No Abstract]   [Full Text] [Related]  

  • 12. Selective cyclooxygenase inhibition: promise for future NSAID therapy?
    Fries JF
    Scand J Rheumatol Suppl; 1996; 102():1. PubMed ID: 8628977
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparative study of subsyde-CR versus meloxicam in rheumatic disorders.
    Patel BR
    J Indian Med Assoc; 2000 May; 98(5):250-2. PubMed ID: 11002624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Selective cyclooxygenase-2 inhibitor].
    Hettich M; Thomae K
    Internist (Berl); 1997 Oct; 38(10):1007. PubMed ID: 9432492
    [No Abstract]   [Full Text] [Related]  

  • 15. [Multicenter study of Felden 20 suppositories in 3887 patients].
    von Criegern T
    Med Welt; 1983 Nov; 34(45):1290-3. PubMed ID: 6358773
    [No Abstract]   [Full Text] [Related]  

  • 16. [The selective inhibition of cyclooxygenase isoforms: a new approach to the search for effective and safe nonsteroidal anti-inflammatory drug agents].
    Viktorov AP
    Lik Sprava; 1997; (5):106-11. PubMed ID: 9491713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coming: a review of second-generation nonsteroidal anti-inflammatory drugs.
    Housholder GT; Chan JT
    J Gt Houst Dent Soc; 1997 Mar; 68(8):13-6. PubMed ID: 9594801
    [No Abstract]   [Full Text] [Related]  

  • 18. [Meloxicam].
    Sternon J; Appelboom T
    Rev Med Brux; 1998 Feb; 19(1):29-32. PubMed ID: 9553452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meloxicam: new formulations and their use in rheumatology.
    Dequeker J; Degner F
    Inflamm Res; 2001 Mar; 50 Suppl 1():S3-4. PubMed ID: 11339518
    [No Abstract]   [Full Text] [Related]  

  • 20. [New information on clinical efficacy and tolerance of meloxicam (movalis)].
    Nasonova VA
    Ter Arkh; 1999; 71(11):45-8. PubMed ID: 10626335
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.